nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—DRD5—eyelid—Graves' disease	0.293	0.56	CbGeAlD
Cabergoline—HTR1D—eye—Graves' disease	0.0196	0.0374	CbGeAlD
Cabergoline—HTR1D—connective tissue—Graves' disease	0.0188	0.036	CbGeAlD
Cabergoline—ADRB1—connective tissue—Graves' disease	0.0183	0.035	CbGeAlD
Cabergoline—HTR7—connective tissue—Graves' disease	0.015	0.0287	CbGeAlD
Cabergoline—DRD2—eye—Graves' disease	0.0147	0.0281	CbGeAlD
Cabergoline—ADRB1—adipose tissue—Graves' disease	0.0141	0.0268	CbGeAlD
Cabergoline—HTR2B—adipose tissue—Graves' disease	0.0135	0.0257	CbGeAlD
Cabergoline—HTR2B—thyroid gland—Graves' disease	0.0116	0.0222	CbGeAlD
Cabergoline—ADRA1A—adipose tissue—Graves' disease	0.0111	0.0212	CbGeAlD
Cabergoline—ADRA2A—connective tissue—Graves' disease	0.011	0.021	CbGeAlD
Cabergoline—DRD2—pituitary gland—Graves' disease	0.0109	0.0209	CbGeAlD
Cabergoline—ADRA2C—pituitary gland—Graves' disease	0.0106	0.0203	CbGeAlD
Cabergoline—ADRA2C—adipose tissue—Graves' disease	0.0106	0.0202	CbGeAlD
Cabergoline—HTR2A—eye—Graves' disease	0.00972	0.0186	CbGeAlD
Cabergoline—HTR2A—connective tissue—Graves' disease	0.00936	0.0179	CbGeAlD
Cabergoline—ADRA2A—pituitary gland—Graves' disease	0.00848	0.0162	CbGeAlD
Cabergoline—ADRA2A—adipose tissue—Graves' disease	0.00845	0.0161	CbGeAlD
Cabergoline—Alopecia—Methimazole—Graves' disease	0.00834	0.057	CcSEcCtD
Cabergoline—Vertigo—Methimazole—Graves' disease	0.00738	0.0505	CcSEcCtD
Cabergoline—ADRA2A—thyroid gland—Graves' disease	0.00731	0.014	CbGeAlD
Cabergoline—HTR2A—pituitary gland—Graves' disease	0.00721	0.0138	CbGeAlD
Cabergoline—Alopecia—Propylthiouracil—Graves' disease	0.00709	0.0485	CcSEcCtD
Cabergoline—Arthralgia—Methimazole—Graves' disease	0.007	0.0478	CcSEcCtD
Cabergoline—Oedema—Methimazole—Graves' disease	0.00671	0.0458	CcSEcCtD
Cabergoline—Vertigo—Propylthiouracil—Graves' disease	0.00628	0.0429	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00611	0.0418	CcSEcCtD
Cabergoline—Paraesthesia—Methimazole—Graves' disease	0.00602	0.0412	CcSEcCtD
Cabergoline—Somnolence—Methimazole—Graves' disease	0.00596	0.0408	CcSEcCtD
Cabergoline—Arthralgia—Propylthiouracil—Graves' disease	0.00595	0.0407	CcSEcCtD
Cabergoline—Dyspepsia—Methimazole—Graves' disease	0.0059	0.0404	CcSEcCtD
Cabergoline—Oedema—Propylthiouracil—Graves' disease	0.0057	0.039	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.0052	0.0355	CcSEcCtD
Cabergoline—Paraesthesia—Propylthiouracil—Graves' disease	0.00512	0.035	CcSEcCtD
Cabergoline—Somnolence—Propylthiouracil—Graves' disease	0.00507	0.0347	CcSEcCtD
Cabergoline—Dyspepsia—Propylthiouracil—Graves' disease	0.00502	0.0343	CcSEcCtD
Cabergoline—Pruritus—Methimazole—Graves' disease	0.00474	0.0324	CcSEcCtD
Cabergoline—Vomiting—Methimazole—Graves' disease	0.00426	0.0291	CcSEcCtD
Cabergoline—Rash—Methimazole—Graves' disease	0.00423	0.0289	CcSEcCtD
Cabergoline—Dermatitis—Methimazole—Graves' disease	0.00422	0.0289	CcSEcCtD
Cabergoline—Headache—Methimazole—Graves' disease	0.0042	0.0287	CcSEcCtD
Cabergoline—Pruritus—Propylthiouracil—Graves' disease	0.00403	0.0276	CcSEcCtD
Cabergoline—Nausea—Methimazole—Graves' disease	0.00398	0.0272	CcSEcCtD
Cabergoline—Vomiting—Propylthiouracil—Graves' disease	0.00363	0.0248	CcSEcCtD
Cabergoline—Rash—Propylthiouracil—Graves' disease	0.0036	0.0246	CcSEcCtD
Cabergoline—Dermatitis—Propylthiouracil—Graves' disease	0.00359	0.0246	CcSEcCtD
Cabergoline—Headache—Propylthiouracil—Graves' disease	0.00357	0.0244	CcSEcCtD
Cabergoline—Nausea—Propylthiouracil—Graves' disease	0.00339	0.0232	CcSEcCtD
Cabergoline—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000994	0.00301	CbGpPWpGaD
Cabergoline—DRD1—Circadian rythm related genes—FAS—Graves' disease	0.00098	0.00297	CbGpPWpGaD
Cabergoline—HTR1A—G alpha (i) signalling events—CXCL10—Graves' disease	0.000967	0.00293	CbGpPWpGaD
Cabergoline—DRD3—Circadian rythm related genes—FAS—Graves' disease	0.000967	0.00293	CbGpPWpGaD
Cabergoline—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000949	0.00287	CbGpPWpGaD
Cabergoline—ADRB1—GPCR ligand binding—TSHR—Graves' disease	0.000948	0.00287	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR ligand binding—TSHR—Graves' disease	0.000939	0.00284	CbGpPWpGaD
Cabergoline—ADRA2C—G alpha (i) signalling events—CXCL10—Graves' disease	0.000936	0.00283	CbGpPWpGaD
Cabergoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000936	0.00283	CbGpPWpGaD
Cabergoline—ADRB2—GPCR ligand binding—TSHR—Graves' disease	0.000927	0.00281	CbGpPWpGaD
Cabergoline—HTR1A—GPCR ligand binding—TSHR—Graves' disease	0.000906	0.00274	CbGpPWpGaD
Cabergoline—HTR2C—GPCR ligand binding—TSHR—Graves' disease	0.000902	0.00273	CbGpPWpGaD
Cabergoline—DRD5—GPCR downstream signaling—TSHR—Graves' disease	0.000897	0.00271	CbGpPWpGaD
Cabergoline—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000895	0.00271	CbGpPWpGaD
Cabergoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000883	0.00267	CbGpPWpGaD
Cabergoline—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000883	0.00267	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR ligand binding—TSHR—Graves' disease	0.000877	0.00266	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR ligand binding—TSHR—Graves' disease	0.000863	0.00261	CbGpPWpGaD
Cabergoline—DRD2—G alpha (i) signalling events—CXCL10—Graves' disease	0.000849	0.00257	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—TSHR—Graves' disease	0.000814	0.00247	CbGpPWpGaD
Cabergoline—ADRA2B—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000805	0.00244	CbGpPWpGaD
Cabergoline—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000804	0.00244	CbGpPWpGaD
Cabergoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000797	0.00241	CbGpPWpGaD
Cabergoline—DRD2—GPCR ligand binding—TSHR—Graves' disease	0.000796	0.00241	CbGpPWpGaD
Cabergoline—HTR7—GPCR ligand binding—CXCL10—Graves' disease	0.00079	0.00239	CbGpPWpGaD
Cabergoline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000787	0.00238	CbGpPWpGaD
Cabergoline—HTR1D—GPCR ligand binding—CXCL10—Graves' disease	0.000785	0.00238	CbGpPWpGaD
Cabergoline—HTR2A—GPCR ligand binding—TSHR—Graves' disease	0.000783	0.00237	CbGpPWpGaD
Cabergoline—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000769	0.00233	CbGpPWpGaD
Cabergoline—HTR1B—GPCR ligand binding—CXCL10—Graves' disease	0.000769	0.00233	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR ligand binding—TSHR—Graves' disease	0.000767	0.00232	CbGpPWpGaD
Cabergoline—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000765	0.00232	CbGpPWpGaD
Cabergoline—ADRA2A—G alpha (i) signalling events—CXCL10—Graves' disease	0.00076	0.0023	CbGpPWpGaD
Cabergoline—DRD4—GPCR ligand binding—CXCL10—Graves' disease	0.000757	0.00229	CbGpPWpGaD
Cabergoline—ADRA2C—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000752	0.00228	CbGpPWpGaD
Cabergoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000744	0.00225	CbGpPWpGaD
Cabergoline—DRD2—Circadian rythm related genes—FAS—Graves' disease	0.00074	0.00224	CbGpPWpGaD
Cabergoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000733	0.00222	CbGpPWpGaD
Cabergoline—HTR2B—GPCR ligand binding—CXCL10—Graves' disease	0.000722	0.00219	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR ligand binding—TSHR—Graves' disease	0.000712	0.00216	CbGpPWpGaD
Cabergoline—HTR7—GPCR downstream signaling—TSHR—Graves' disease	0.000691	0.00209	CbGpPWpGaD
Cabergoline—HTR1D—GPCR downstream signaling—TSHR—Graves' disease	0.000687	0.00208	CbGpPWpGaD
Cabergoline—DRD1—GPCR ligand binding—CXCL10—Graves' disease	0.000681	0.00206	CbGpPWpGaD
Cabergoline—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000675	0.00205	CbGpPWpGaD
Cabergoline—HTR1B—GPCR downstream signaling—TSHR—Graves' disease	0.000672	0.00204	CbGpPWpGaD
Cabergoline—DRD3—GPCR ligand binding—CXCL10—Graves' disease	0.000672	0.00204	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR ligand binding—CXCL10—Graves' disease	0.000672	0.00204	CbGpPWpGaD
Cabergoline—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000665	0.00201	CbGpPWpGaD
Cabergoline—DRD4—GPCR downstream signaling—TSHR—Graves' disease	0.000662	0.002	CbGpPWpGaD
Cabergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000651	0.00197	CbGpPWpGaD
Cabergoline—HTR2B—GPCR downstream signaling—TSHR—Graves' disease	0.000632	0.00191	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—TSHR—Graves' disease	0.000628	0.0019	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—TSHR—Graves' disease	0.000624	0.00189	CbGpPWpGaD
Cabergoline—ADRB1—GPCR ligand binding—CXCL10—Graves' disease	0.000612	0.00185	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—TSHR—Graves' disease	0.000611	0.00185	CbGpPWpGaD
Cabergoline—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.00061	0.00185	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR ligand binding—CXCL10—Graves' disease	0.000607	0.00184	CbGpPWpGaD
Cabergoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000605	0.00183	CbGpPWpGaD
Cabergoline—HTR1A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000604	0.00183	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—TSHR—Graves' disease	0.000601	0.00182	CbGpPWpGaD
Cabergoline—ADRB2—GPCR ligand binding—CXCL10—Graves' disease	0.000599	0.00181	CbGpPWpGaD
Cabergoline—DRD1—GPCR downstream signaling—TSHR—Graves' disease	0.000596	0.0018	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—TSHR—Graves' disease	0.000588	0.00178	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—TSHR—Graves' disease	0.000588	0.00178	CbGpPWpGaD
Cabergoline—HTR1A—GPCR ligand binding—CXCL10—Graves' disease	0.000586	0.00177	CbGpPWpGaD
Cabergoline—HTR2C—GPCR ligand binding—CXCL10—Graves' disease	0.000583	0.00176	CbGpPWpGaD
Cabergoline—DRD5—GPCR downstream signaling—CXCL10—Graves' disease	0.000579	0.00175	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—TSHR—Graves' disease	0.000574	0.00174	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR ligand binding—CXCL10—Graves' disease	0.000567	0.00172	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR ligand binding—CXCL10—Graves' disease	0.000558	0.00169	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—TSHR—Graves' disease	0.000541	0.00164	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—TSHR—Graves' disease	0.000536	0.00162	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—TSHR—Graves' disease	0.000534	0.00162	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—TSHR—Graves' disease	0.000534	0.00162	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—TSHR—Graves' disease	0.000531	0.00161	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—CXCL10—Graves' disease	0.000526	0.00159	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—TSHR—Graves' disease	0.000524	0.00159	CbGpPWpGaD
Cabergoline—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000522	0.00158	CbGpPWpGaD
Cabergoline—DRD2—GPCR ligand binding—CXCL10—Graves' disease	0.000514	0.00156	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	0.000512	0.00155	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—TSHR—Graves' disease	0.00051	0.00154	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—GC—Graves' disease	0.000506	0.00153	CbGpPWpGaD
Cabergoline—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	0.000506	0.00153	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—TSHR—Graves' disease	0.000496	0.0015	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR ligand binding—CXCL10—Graves' disease	0.000495	0.0015	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—TSHR—Graves' disease	0.000488	0.00148	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—TSHR—Graves' disease	0.000486	0.00147	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—TSHR—Graves' disease	0.000482	0.00146	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—TSHR—Graves' disease	0.000481	0.00146	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—TSHR—Graves' disease	0.000476	0.00144	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—TSHR—Graves' disease	0.000465	0.00141	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—TSHR—Graves' disease	0.000463	0.0014	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	0.00046	0.00139	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—TSHR—Graves' disease	0.00045	0.00136	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—TSHR—Graves' disease	0.00045	0.00136	CbGpPWpGaD
Cabergoline—HTR7—GPCR downstream signaling—CXCL10—Graves' disease	0.000447	0.00135	CbGpPWpGaD
Cabergoline—HTR1D—GPCR downstream signaling—CXCL10—Graves' disease	0.000444	0.00134	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—TSHR—Graves' disease	0.000443	0.00134	CbGpPWpGaD
Cabergoline—DRD5—GPCR downstream signaling—IL2RA—Graves' disease	0.000443	0.00134	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	0.000443	0.00134	CbGpPWpGaD
Cabergoline—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000438	0.00133	CbGpPWpGaD
Cabergoline—HTR1B—GPCR downstream signaling—CXCL10—Graves' disease	0.000435	0.00132	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—TSHR—Graves' disease	0.000433	0.00131	CbGpPWpGaD
Cabergoline—DRD4—GPCR downstream signaling—CXCL10—Graves' disease	0.000428	0.00129	CbGpPWpGaD
Cabergoline—ADRA2B—Hemostasis—IL2RA—Graves' disease	0.000415	0.00126	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—GC—Graves' disease	0.000411	0.00125	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—TSHR—Graves' disease	0.000408	0.00124	CbGpPWpGaD
Cabergoline—HTR2B—GPCR downstream signaling—CXCL10—Graves' disease	0.000408	0.00124	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—CXCL10—Graves' disease	0.000406	0.00123	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—CXCL10—Graves' disease	0.000403	0.00122	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	0.000403	0.00122	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—IL2RA—Graves' disease	0.000402	0.00122	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—TSHR—Graves' disease	0.000402	0.00122	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—CXCL10—Graves' disease	0.000395	0.00119	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—TSHR—Graves' disease	0.000394	0.00119	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—CXCL10—Graves' disease	0.000388	0.00118	CbGpPWpGaD
Cabergoline—ADRA2C—Hemostasis—IL2RA—Graves' disease	0.000387	0.00117	CbGpPWpGaD
Cabergoline—DRD1—GPCR downstream signaling—CXCL10—Graves' disease	0.000385	0.00117	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—B3GNT2—Graves' disease	0.000384	0.00116	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—CXCL10—Graves' disease	0.00038	0.00115	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—CXCL10—Graves' disease	0.00038	0.00115	CbGpPWpGaD
Cabergoline—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000379	0.00115	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TSHR—Graves' disease	0.000371	0.00112	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—CXCL10—Graves' disease	0.000371	0.00112	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TSHR—Graves' disease	0.000368	0.00112	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	0.000366	0.00111	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TSHR—Graves' disease	0.000361	0.00109	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TSHR—Graves' disease	0.000355	0.00107	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—CXCL10—Graves' disease	0.00035	0.00106	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—CXCL10—Graves' disease	0.000346	0.00105	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—CXCL10—Graves' disease	0.000345	0.00104	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—CXCL10—Graves' disease	0.000345	0.00104	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—CXCL10—Graves' disease	0.000343	0.00104	CbGpPWpGaD
Cabergoline—HTR7—GPCR downstream signaling—IL2RA—Graves' disease	0.000341	0.00103	CbGpPWpGaD
Cabergoline—HTR1D—GPCR downstream signaling—IL2RA—Graves' disease	0.000339	0.00103	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TSHR—Graves' disease	0.000339	0.00103	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—CXCL10—Graves' disease	0.000339	0.00103	CbGpPWpGaD
Cabergoline—HTR1B—GPCR downstream signaling—IL2RA—Graves' disease	0.000332	0.00101	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	0.000331	0.001	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—CXCL10—Graves' disease	0.000329	0.000997	CbGpPWpGaD
Cabergoline—DRD4—GPCR downstream signaling—IL2RA—Graves' disease	0.000327	0.00099	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—CXCL10—Graves' disease	0.00032	0.00097	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TSHR—Graves' disease	0.00032	0.000968	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TSHR—Graves' disease	0.000315	0.000955	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TSHR—Graves' disease	0.000315	0.000955	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—CXCL10—Graves' disease	0.000315	0.000955	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—IL2RA—Graves' disease	0.000315	0.000953	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—CXCL10—Graves' disease	0.000314	0.000952	CbGpPWpGaD
Cabergoline—HTR2B—GPCR downstream signaling—IL2RA—Graves' disease	0.000312	0.000945	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—B3GNT2—Graves' disease	0.000312	0.000944	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—CXCL10—Graves' disease	0.000311	0.000943	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—CXCL10—Graves' disease	0.000311	0.000941	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—IL2RA—Graves' disease	0.00031	0.000939	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—IL2RA—Graves' disease	0.000308	0.000933	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—CXCL10—Graves' disease	0.000307	0.000931	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—IL2RA—Graves' disease	0.000302	0.000913	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	0.000301	0.00091	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—CXCL10—Graves' disease	0.000299	0.000906	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—IL2RA—Graves' disease	0.000297	0.000899	CbGpPWpGaD
Cabergoline—DRD1—GPCR downstream signaling—IL2RA—Graves' disease	0.000294	0.000891	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—CXCL10—Graves' disease	0.000291	0.000881	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	0.000291	0.00088	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—IL2RA—Graves' disease	0.00029	0.000879	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—IL2RA—Graves' disease	0.00029	0.000879	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TSHR—Graves' disease	0.000287	0.00087	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—CXCL10—Graves' disease	0.000286	0.000867	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	0.000286	0.000866	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TSHR—Graves' disease	0.000285	0.000862	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—IL2RA—Graves' disease	0.000283	0.000858	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TSHR—Graves' disease	0.000281	0.000851	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—CXCL10—Graves' disease	0.00028	0.000848	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TSHR—Graves' disease	0.000275	0.000832	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TSHR—Graves' disease	0.000273	0.000828	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—IL2RA—Graves' disease	0.000267	0.000809	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TSHR—Graves' disease	0.000266	0.000805	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—IL2RA—Graves' disease	0.000265	0.000801	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—CXCL10—Graves' disease	0.000264	0.000799	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—IL2RA—Graves' disease	0.000264	0.000798	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—IL2RA—Graves' disease	0.000264	0.000798	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—IL2RA—Graves' disease	0.000262	0.000794	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TSHR—Graves' disease	0.000262	0.000792	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	0.00026	0.000788	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	0.00026	0.000786	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—IL2RA—Graves' disease	0.000259	0.000784	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—CXCL10—Graves' disease	0.000254	0.00077	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	0.000253	0.000766	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—IL2RA—Graves' disease	0.000252	0.000762	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—IL2RA—Graves' disease	0.000245	0.000741	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TSHR—Graves' disease	0.000241	0.000731	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—IL2RA—Graves' disease	0.000241	0.00073	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—IL2RA—Graves' disease	0.00024	0.000727	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—CXCL10—Graves' disease	0.00024	0.000726	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—CXCL10—Graves' disease	0.000238	0.000721	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—IL2RA—Graves' disease	0.000238	0.000721	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—IL2RA—Graves' disease	0.000238	0.000719	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TSHR—Graves' disease	0.000237	0.000719	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	0.000236	0.000715	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—IL2RA—Graves' disease	0.000235	0.000712	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—CXCL10—Graves' disease	0.000233	0.000706	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TSHR—Graves' disease	0.000232	0.000704	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	0.00023	0.000696	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—CXCL10—Graves' disease	0.000229	0.000695	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—IL2RA—Graves' disease	0.000229	0.000692	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—IL2RA—Graves' disease	0.000222	0.000673	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	0.000222	0.000673	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CXCL10—Graves' disease	0.000219	0.000663	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—IL2RA—Graves' disease	0.000219	0.000663	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	0.000219	0.000662	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TSHR—Graves' disease	0.000216	0.000654	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—IL2RA—Graves' disease	0.000214	0.000648	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CXCL10—Graves' disease	0.000207	0.000625	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CXCL10—Graves' disease	0.000204	0.000617	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CXCL10—Graves' disease	0.000204	0.000617	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—IL2RA—Graves' disease	0.000202	0.000611	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	0.000199	0.000602	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	0.000198	0.000601	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL2RA—Graves' disease	0.000194	0.000589	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CXCL10—Graves' disease	0.000186	0.000562	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CXCL10—Graves' disease	0.000184	0.000557	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL2RA—Graves' disease	0.000183	0.000555	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL2RA—Graves' disease	0.000182	0.000551	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CXCL10—Graves' disease	0.000182	0.00055	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	0.000181	0.000547	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL2RA—Graves' disease	0.000178	0.00054	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CXCL10—Graves' disease	0.000178	0.000538	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CXCL10—Graves' disease	0.000177	0.000535	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL2RA—Graves' disease	0.000175	0.000531	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GC—Graves' disease	0.000175	0.000531	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CXCL10—Graves' disease	0.000172	0.00052	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CXCL10—Graves' disease	0.000169	0.000512	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL2RA—Graves' disease	0.000167	0.000507	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL2RA—Graves' disease	0.000158	0.000478	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CXCL10—Graves' disease	0.000156	0.000472	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL2RA—Graves' disease	0.000156	0.000472	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL2RA—Graves' disease	0.000156	0.000472	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CXCL10—Graves' disease	0.000153	0.000465	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CXCL10—Graves' disease	0.00015	0.000455	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL2RA—Graves' disease	0.000142	0.00043	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL2RA—Graves' disease	0.000141	0.000426	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	0.00014	0.000423	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL2RA—Graves' disease	0.000139	0.00042	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL2RA—Graves' disease	0.000136	0.000411	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL2RA—Graves' disease	0.000135	0.000409	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—B3GNT2—Graves' disease	0.000133	0.000402	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL2RA—Graves' disease	0.000131	0.000398	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL2RA—Graves' disease	0.000129	0.000391	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL2RA—Graves' disease	0.000119	0.000361	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL2RA—Graves' disease	0.000117	0.000355	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL2RA—Graves' disease	0.000115	0.000348	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	0.000107	0.000323	CbGpPWpGaD
